First use of cenerimod, a selective S1P 1 receptor modulator, for the treatment of SLE: A double-blind, randomised, placebo-controlled, proof-of-concept study

Hermann, V., Batalov, A., Smakotina, S., Juif, P., & Cornelisse, P. (). First use of cenerimod, a selective S1P 1 receptor modulator, for the treatment of SLE: A double-blind, randomised, placebo-controlled, proof-of-concept study. Lupus Science and Medicine; Lupus Science and Medicine.